Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.19.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Cash flows from operating activities:      
Net loss $ (48,218) $ (27,893)  
Adjustments to reconcile net loss to cash used in operating activities:      
Depreciation 74 64 $ 136
Share-based compensation expense 1,113 404  
Gain on short-term investments (100)    
Non-cash gain on short-term investments   (62)  
Interest on short-term investments (74) (71)  
Amortization of debt discount and deferred financing costs 170 138  
Other 58 245  
Changes in operating assets and liabilities:      
Prepaid expenses and other current assets 511 (1,563)  
Other assets (82) (1,065)  
Accounts payable 6,118 5,014  
Accrued expenses 6,923 94  
Income taxes 47 60  
Other liabilities   65  
Net cash used in operating activities (33,460) (24,570)  
Cash flows from investing activities:      
Purchases of property and equipment (22) (53)  
Purchases of short-term investments   (53,727)  
Proceeds from sale of short-term investments 40,100 34,150  
Net cash provided by / (used in) investing activities 40,078 (19,630)  
Cash flows from financing activities:      
Proceeds from issuance of debt, net of debt issuance costs   14,507  
Proceeds from issuance of ordinary shares, net of issuance costs 74,200 74,155  
Proceeds from exercise of share options 60    
Net cash provided by financing activities 60 120,835  
Effect of exchange rates on cash and cash equivalents (18) (99)  
Net increase in cash, cash equivalents and restricted cash 6,660 76,536  
Cash, cash equivalents and restricted cash, at beginning of period 44,671 8,485 8,485
Cash, cash equivalents and restricted cash, at end of period 51,331 85,021 $ 44,671
Supplemental Disclosure of Cash Flow Information:      
Income tax paid - US 244 96  
Interest paid $ 710 126  
Series B Convertible Preferred Shares      
Cash flows from financing activities:      
Proceeds from issuance of Series B convertible preferred shares, net of issuance costs   $ 32,173